ECOR (electroCore) Operating Cash Flow per Share : $-1.10 (TTM As of Mar. 2025)

View and export this data going back to 2018. Start your Free Trial

What is electroCore Operating Cash Flow per Share?

electroCore's operating cash flow per share for the three months ended in Mar. 2025 was $-0.53. electroCore's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2025 was $-1.10.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 35.50% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 42.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for electroCore's Operating Cash Flow per Share or its related term are showing as below:

ECOR' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -159.4 Med: 32.7 Max: 47.7
Current: 35.5

During the past 9 years, electroCore's highest 3-Year average Operating Cash Flow per Share Growth Rate was 47.70% per year. The lowest was -159.40% per year. And the median was 32.70% per year.

ECOR's 3-Year OCF Growth Rate is ranked better than
80.86% of 695 companies
in the Medical Devices & Instruments industry
Industry Median: 8.3 vs ECOR: 35.50

electroCore Operating Cash Flow per Share Historical Data

The historical data trend for electroCore's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

electroCore Operating Cash Flow per Share Chart

electroCore Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Operating Cash Flow per Share

Get a 7-Day Free Trial

-7.71

-3.46

-3.52

-2.66

-0.93

electroCore Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Operating Cash Flow per Share	Get a 7-Day Free Trial															-0.39	-0.25	-0.17	-0.15	-0.53

Competitive Comparison of electroCore's Operating Cash Flow per Share

For the Medical Devices subindustry, electroCore's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

electroCore's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, electroCore's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where electroCore's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

electroCore Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

electroCore's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (A: Dec. 2024 )	=	Cash Flow from Operations (A: Dec. 2024 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2024 )
	=	-6.948	/	7.483
	=	-0.93

electroCore's Operating Cash Flow per Share for the quarter that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (Q: Mar. 2025 )	=	Cash Flow from Operations (Q: Mar. 2025 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2025 )
	=	-4.355	/	8.289
	=	-0.53

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.10

electroCore Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of electroCore's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

electroCore Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » electroCore Inc (NAS:ECOR) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

43E0:Germany

Address

200 Forge Way, Suite 205, Rockaway, NJ, USA, 07866

Website

https://www.electrocore.com

electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.

Executives

John P Gandolfo	director	62 TERRACE ROAD, WAYNE NJ 07470
Thomas J. Errico	director, 10 percent owner	150 ALLEN ROAD, SUITE 201, BASKING RIDGE NJ 97920
Daniel S Goldberger	director, officer: Chief Executive Officer	24 CARPENTER ROAD, CHESTER NY 10918
Joseph P Errico	director, 10 percent owner, officer: See Remarks	150 ALLEN ROAD, SUITE 201, BASKING RIDGE NJ 07920
Trevor J Moody	director	150 ALLEN ROAD, SUITE 201, BASKING RIDGE NJ 07920
Julie Ann Goldstein	director	205 FORGE WAY, ROCKAWAY NJ 07866
Patricia Wilber	director	205 FORGE WAY, SUITE 205, ROCKAWAY NJ 07866
Brian M Posner	officer: Chief Financial Officer	1590 REED ROAD, PENNINGTON NJ 08534
Tullis James L L	director	100 FIRST STAMFORD PLACE, STAMFORD CT 06907
Thomas M Patton	director	C/O OSTEOTCH INC., 51 JAMES WAY, EATONTOWN NJ 07724
F Peter Cuneo	director	10 EAST 40TH ST, NEW YORK NY 10016
Stephen Ondra	director	150 ALLEN ROAD, SUITE 201, BASKING RIDGE NJ 07920
Nicholas Colucci	director	150 ALLEN ROAD, SUITE 201, BASKING RIDGE NJ 07920
Michael G Atieh	director	MERCK MEDCO MANAGED CARE INC, 100 SUMMIT AVE, MONTVALE NJ 07645
Carrie Smith Cox	director	SCHERING-PLOUGH CORPORATION, 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033